Correlation Between Peak Serum Bilirubin During 1st Week of Life and Future Neurodevelopmental Outcome in Healthy Term Babies

Article Sidebar

PDF
Published: Mar 22, 2022
DOI: https://doi.org/10.55184/ijpas.v72i1.22
Keywords:
bilirubin neurodevelopment term babies

Main Article Content

Sandip Samanta
a:1:{s:5:"en_US";s:129:"Department of Paediatric Medicine, Dr. B. C. Roy Post Graduate Institute of Paediatric Sciences, Kolkata – 700 054, West Bengal";}
Indrani Das
Department of Gynecology & Obstetrics, Medical College, Kolkata, West Bengal
Purnima Kolli
Dept of Paediatric, Dr. B. C. Roy Post Graduate Institute of Paediatric Science, Kolkata, West bengal
Suprit Basu
Dept of Paediatric, Dr. B. C. Roy Post Graduate Institute of Paediatric Science, Kolkata , West Bengal
Debanjan Sinha
Dept of Paediatric, Dr. B. C. Roy Post Graduate Institute of Paediatric Science, Kolkata, West Bengal
Pradip Maiti
Dept of Physiotherapy, Dr. B. C. Roy PGIPS, Kolkata, West Bengal

Abstract

Study was done to look for the future neurodevelopmental outcome of the babies with extremely high serum bilirubin level at 1st week of life. Fifty one term and near term babies were enrolled with features of acute bilirubin encephalopathy (ABE), with bilirubin level more than20mg/dl. They were followed up at 3rd and 6th month to observe their neurodevelopment. Neurological outcome was measured with Denver Development Screening Test (DDST-II) and brainstem evoked response audiometry (BERA). The mean peak total serum bilirubin (TSB) was 25.3±2.35(mg/dl). Abnormal developmental was found in 23.5% babies (12 out of 51) and abnormalities were more in the babies whose TSB was beyond 28mg/dl. Abnormal BERA was found among 13.7% babies. TSB value below 25 mg/dl can be considered as safe cut off value for reversibility of bilirubin induced acute brain damage.

Article Details

How to Cite
Samanta, S., Das, I., Kolli, P., Basu, S., Sinha, D., & Maiti, P. (2022). Correlation Between Peak Serum Bilirubin During 1st Week of Life and Future Neurodevelopmental Outcome in Healthy Term Babies. INDIAN JOURNAL OF PHYSIOLOGY AND ALLIED SCIENCES, 72(1). https://doi.org/10.55184/ijpas.v72i1.22
Issue
Vol. 72 No. 1 (2020): INDIAN JOURNAL OF PHYSIOLOGY AND ALLIED SCIENCES
Section
Research Article

References

Ambalavan N, Carlo A .(2016): Jaundice and hyperbilirubinemia in the newborn. In: Nelson Textbook of Paediatrics (Kleigman M, Stanton F. eds.) 20th ed. p.871

Bratlid D. How bilirubin gets into the brain. Clin Perinatol.1990;17:449–65.

Babu TA, Bhat V, Joseph NM. Association between peak serum bilirubin and neurodevelopmental outcomes in term babies with hyperbilirubinemia. The Indian Journal of Pediatrics. 2012 Feb 1;79(2):202-6.

Cashore WJ, The neurotoxicity of bilirubin.Clin Perinatol. 1990;17:437–47.

Ip S, Chung M, Kulig J, O Brien R, Sege R, Glicken S, Maisels MJ, Lau J, American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. PEDIATRICS-SPRINGFIELD-.. 2004 Jul 1;114:249-50.

Johnson L, Brown AK, Bhutani VK. BIND—a clinicalscore bilirubin induced neurologic dysfunction in neonates.Pediatr Suppl 1999;104:746.

Kumar M, Tripathi S, Singh SN, Anand V. Outcome of neonates with severe hyperbilirubinemia in a tertiary level neonatal unit of North India. Clinical Epidemiology and Global Health. 2016 Jun 1;4(2):51-6.

Mukhopadhyay K, Chowdhary G, Singh P, Kumar P, Narang A. Neurodevelopmental outcome of acute bilirubin encephalopathy. Journal of tropical pediatrics. 2010 Feb 1;56(5):333-6.

Stark AR, Bhutani VK : Neonatal Hyperbilirubinemia. In : Cloherty and Stark’s Manual of Neonatal Care (Eichenwald EC, Hansen AR .eds) 8th ed:2016; Pp 349-50.

Usman, F., Diala, U.M., Shapiro, S.M., Le Pichon, J.B. and Slusher, T.M., 2018. Acute bilirubin encephalopathy and its progression to kernicterus: current perspectives.

Weinberg RP, Cellular basis of bilirubin toxicity. N Y State J Med.1991;91:493-6